PIK3CA and lymphangioma: In a cohort of 31 LM patients from the Seattle Children’s Hospital, 74% showed activating PIK3CA mutations; and even more significantly, 16 out of 17 LM patients from the Boston Children's Hospital had PIK3CA mutations [7].